Zephyr Valve Registry (ZEVR)

Active, not recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

November 25, 2019

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Emphysema
Interventions
DEVICE

Zephyr Valve Procedure

The Pulmonx Zephyr Endobronchial Valve is an implantable bronchial valve intended to decrease volume in targeted regions of the lung. It is indicated for the treatment of patients with severe emphysema. The Zephyr Valves are placed in the diseased region of the lung using bronchoscopy. As the diseased region of the lung shrinks in size, healthier regions may expand and function more efficiently, resulting in improved breathing.

Trial Locations (11)

15123

University of Pittsburgh School of Medicine, Pittsburgh

15801

The Lung Center, DuBois

19104

University of Pennsylvania, Philadelphia

19140

Temple University Hospital, Philadelphia

22031

Inova Health, Fairfax

35294

University of Alabama at Birmingham, Birmingham

48202

Henry Ford Hospital, Detroit

53226

Froedtert Memorial-Medical College of Wisconsin, Milwaukee

60190

Northwestern Medicine, Winfield

60637

University of Chicago, Chicago

77030

Houston Methodist, Houston

All Listed Sponsors
lead

Pulmonx Corporation

INDUSTRY

NCT04186546 - Zephyr Valve Registry (ZEVR) | Biotech Hunter | Biotech Hunter